TrueBlue Reports Wider Q1 Loss, Significant Margin Contraction, and New Goodwill Impairment
Summary
TrueBlue, Inc. reported a wider net loss of $19.8 million for Q1 2026, alongside a significant 350 basis point contraction in gross profit margin and a $3.7 million goodwill impairment, despite revenue growth and improved SG&A.
Key Events
-
Net Loss Widens Significantly
The company reported a net loss of $19.8 million, or $(0.66) per diluted share, for Q1 2026, compared to a net loss of $14.3 million, or $(0.48) per diluted share, in Q1 2025. This continues the trend of net losses from fiscal 2025.
-
Gross Profit Margin Contracts Sharply
Gross profit as a percentage of revenue declined by 350 basis points to 19.8% in Q1 2026 from 23.3% in the prior year. This contraction was primarily due to higher workers' compensation costs (220 basis points) and an unfavorable revenue mix (130 basis points).
-
Goodwill Impairment Charge Recorded
A non-cash goodwill impairment charge of $3.7 million was recognized for the Healthcare Staffing Professionals (HSP) reporting unit. This impairment was triggered by a lower share price, market capitalization, and downward revisions to future projections, following a $59.1 million charge in fiscal 2024.
-
Revenue Growth Amidst Profitability Challenges
Total company revenue grew 7.6% to $398.6 million, driven by growth in skilled businesses (energy and commercial driving), partially offset by declines in on-demand, on-site, and permanent hiring segments.
Analysis
TrueBlue, Inc. reported a challenging first quarter for 2026, with a wider net loss and substantial gross profit margin contraction, indicating ongoing operational headwinds. The company's net loss increased to $19.8 million, a significant deterioration from the prior year, continuing a trend of losses seen in fiscal 2025. A key driver of the margin decline was a sharp increase in workers' compensation costs, which had a material impact on profitability. Additionally, a $3.7 million goodwill impairment charge was recorded for the Healthcare Staffing Professionals (HSP) unit, signaling continued underperformance in this segment. While revenue saw growth, and SG&A expenses improved due to cost management, these positives were overshadowed by the profitability issues. The company also disclosed a cooperation agreement with an activist investor, which resolves a potential proxy contest and provides governance stability, but does not directly address the financial performance challenges.
At the time of this filing, TBI was trading at $6.13 on NYSE in the Trade & Services sector, with a market capitalization of approximately $181.6M. The 52-week trading range was $3.18 to $7.78. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.